Clinical Trial Update: Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

View source ↗

Summary

The clinical trial examining changes in keratometric value and ocular aberration after treatment for meibomian gland dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction

Snippet

Sponsor: Yonsei University | Conditions: Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction) | Status: WITHDRAWN